Antonio Cannatà, MD; Marco Merlo, MD; Matteo Dal Ferro, MD; et al.
free access
JAMA Cardiol. 2022;7(4):371-377. doi:10.1001/jamacardio.2021.5890
This cohort study investigated the genetic background and the natural history of a large international cohort of dilated cardiomyopathy presenting in individuals older than 60 years to assess the importance of genetic testing in those patients.
Alessio Gasperetti, MD; Chiara Cappelletto, MD; Richard Carrick, MD, PhD; et al.
free access
JAMA Cardiol. 2022;7(4):378-385. doi:10.1001/jamacardio.2021.6016
This cohort study describes changes in premature ventricular contraction burden over time and assesses whether a changing burden on follow-up Holter monitoring is associated with subsequent arrhythmic events in patients with arrhythmogenic right ventricular cardiomyopathy.
Grant Duffy, BS; Paul P. Cheng, MD, PhD; Neal Yuan, MD; et al.
open access
has multimedia
JAMA Cardiol. 2022;7(4):386-395. doi:10.1001/jamacardio.2021.6059
This cohort study assesses the accuracy of a deep learning algorithm in measuring left ventricular dimensions and identifying patients with increased wall thickness who may benefit from additional screening for hypertrophic cardiomyopathy and cardiac amyloidosis.
-
Video:
Deep Learning Prediction of Left Ventricular Dimensions and Screening for Cardiac Amyloidosis and Hypertrophic Cardiomyopathy
Seyedeh Maryam Zekavat, BS; Elizabeth L. Chou, MD; Melica Zekavat; et al.
free access
JAMA Cardiol. 2022;7(4):396-406. doi:10.1001/jamacardio.2022.0001
This case-control study assesses which genes contribute to the development of spontaneous coronary artery dissection.
Hirotoshi Watanabe, MD; Takeshi Morimoto, MD; Masahiro Natsuaki, MD; et al.
free access
JAMA Cardiol. 2022;7(4):407-417. doi:10.1001/jamacardio.2021.5244
This randomized clinical trial evaluates whether 1 to 2 months of dual antiplatelet therapy (DAPT) followed by clopidogrel monotherapy is noninferior to 12 months of DAPT with aspirin and clopidogrel for patients with acute coronary syndromes.
Doyeon Hwang, MD; Young-Hyo Lim, MD; Kyung Woo Park, MD; et al.
free access
JAMA Cardiol. 2022;7(4):418-426. doi:10.1001/jamacardio.2022.0052
This post hoc analysis investigates whether the benefits of prasugrel dose de-escalation therapy are maintained in the complex percutaneous coronary intervention subgroup.
Tania Coscia, MD; Thomas Nestelberger, MD; Jasper Boeddinghaus, MD; et al.
free access
JAMA Cardiol. 2022;7(4):427-434. doi:10.1001/jamacardio.2022.0043
This cohort study explores the characteristics and outcomes of patients with type 2 myocardial infarction compared with those with type 1 myocardial infarction.
Edina Hadziselimovic, MD; Anders M. Greve, MD, PhD; Ahmad Sajadieh, MD, DMSc; et al.
free access
has audio
JAMA Cardiol. 2022;7(4):435-444. doi:10.1001/jamacardio.2021.5916
This substudy of a randomized clinical trial examines the association between annual measurement of N-terminal pro-brain natriuretic peptide levels and outcomes in patients with aortic stenosis.
-
Podcast:
N-Terminal Pro-Brain Natriuretic Peptide Measurements in Patients With Aortic Stenosis